| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.2M | -60.5% |
| Cost of Revenue | $8.5M | -25.9% |
| Gross Profit | -$5.2M | -62.8% |
| R&D Expense | $103.1M | +42.1% |
| SG&A Expense | $61.5M | +53.9% |
| Operating Income | -$169.8M | -46.7% |
| Pre-tax Income | -$220.5M | -31.8% |
| Income Tax | $3.5M | +425.3% |
| Net Income | -$224.0M | -33.3% |
| EPS (Basic) | -$1.72 | -3.6% |
| EPS (Diluted) | -$1.72 | -3.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.0M | -37.5% |
| Accounts Receivable | $122K | -91.0% |
| Current Assets | $62.4M | -47.7% |
| Total Assets | $83.6M | -48.7% |
| Current Liabilities | $178.8M | +245.3% |
| Total Liabilities | $182.9M | +210.0% |
| Stockholders' Equity | -$99.4M | -195.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$126.2M | -0.2% |
| Capital Expenditures | $4.5M | -43.2% |
| Investing Cash Flow | $40.6M | +176.9% |
| Financing Cash Flow | $71.8M | -63.5% |
| Free Cash Flow | -$130.7M | +2.4% |